| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.002 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.18 | 0.003 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.095 | 0.005 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.094 | 0.005 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.006 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.088 | 0.006 |